Gail Wilensky - UnitedHealth Group Independent Director
| UNH Stock | MXN 12,124 30.40 0.25% |
Director
Dr. Gail R. Wilensky, Ph.D. is Independent Director of the Company. Dr. Wilensky was a senior fellow at Project HOPE, an international health foundation, since 1993. From 2008 to 2009, Dr. Wilensky was President of the Department of Defense Health Board and chaired its subcommittee on health care delivery. From 2006 to 2008, Dr. Wilensky cochaired the Department of Defense Task Force on the Future of Military Health Care. During 2007 she also served as a commissioner on the President Commission on Care for America Returning Wounded Warriors. From 2001 to 2003, she was the CoChair of the President Task Force to Improve Health Care for our Nation Veterans. From 1997 to 2001, she was also Chair of the Medicare Payment Advisory Commission. From 1992 to 1993, Dr. Wilensky served as the Deputy Assistant to President George H. W. Bush for policy development, and from 1990 to 1992, she was the Administrator of the Health Care Financing Administration directing the Medicaid and Medicare programs for the United States. Dr. Wilensky is a nationally recognized health care economist. Dr. Wilensky currently serves as a director of Quest Diagnostics Incorporated. since 1993.
| Age | 75 |
| Tenure | 31 years |
| Phone | 952 936 1300 |
| Web | https://www.unitedhealthgroup.com |
UnitedHealth Group Management Efficiency
The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Luis Platas | Grupo Sports World | N/A | |
| Jose Rionda | Grupo Sports World | N/A | |
| Hadi Ibrahim | Grupo Sports World | 42 | |
| Fernando Lopez | Grupo Sports World | 35 | |
| Cynthia Ayon | Grupo Sports World | 52 | |
| Alfredo Torrado | Grupo Sports World | N/A | |
| Patricia Menendez | Grupo Sports World | N/A | |
| Hector Rivero | Grupo Sports World | N/A | |
| Fabian Castro | Grupo Sports World | N/A | |
| Humberto Herrera | Grupo Sports World | 46 | |
| Andrea Fossa | Grupo Sports World | N/A | |
| Omar Serio | Grupo Sports World | N/A | |
| Michael Salvino | DXC Technology | 58 | |
| Victor Garcia | Grupo Sports World | N/A | |
| Cosme Martinez | Grupo Sports World | 56 | |
Management Performance
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 |
UnitedHealth Group Leadership Team
Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gail Wilensky, Independent Director | ||
| Richard Burke, Independent Chairman of the Board | ||
| Valerie Rice, Independent Director | ||
| Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director | ||
| Sir Witty, CEO Director | ||
| Stephen Hemsley, Non-Executive Chairman of the Board | ||
| John Rex, Chief Financial Officer, Executive Vice President | ||
| Dirk McMahon, Chief Executive Officer - UnitedHealthcare | ||
| Zachary Sopcak, VP Relations | ||
| John Noseworthy, Independent Director | ||
| Jennifer Smoter, VP Officer | ||
| William Ballard, Independent Director | ||
| Glenn Renwick, Independent Director | ||
| Rupert Bondy, Ex Officer | ||
| Sandeep Dadlani, Ex Officer | ||
| Michele Hooper, Independent Director | ||
| Timothy Flynn, Independent Director | ||
| Thomas Roos, Senior Vice President, Chief Accounting Officer | ||
| Matthew Friedrich, Executive Vice President Chief Legal Officer | ||
| D Wilson, Executive Vice President - Human Capital | ||
| F McNabb, Independent Director | ||
| Marianne Short, Executive Vice President Chief Legal Officer | ||
| David Wichmann, CFO, Executive Vice President and Presidentident - UnitedHealth Group Operations | ||
| Brian Thompson, Ex UnitedHealthcare | ||
| James Barry, Director Pennsylvania |
UnitedHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0776 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 9.95 T | |||
| Shares Outstanding | 934.35 M | |||
| Shares Owned By Insiders | 0.46 % | |||
| Shares Owned By Institutions | 89.00 % | |||
| Price To Earning | 25.88 X | |||
| Price To Book | 6.64 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for UnitedHealth Stock Analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.